Azura Ophthalmics is a startup based in Israel, 1 tracked investor.
Based in Israel, Azura Ophthalmics is a startup founded in 2014. Brouky records 1 investor associated with the company.
Azura Ophthalmics develops first-in-class ophthalmic keratolytic therapeutics focusing on treating eye diseases related to meibomian gland dysfunction and dry eye disease by targeting the root causes of ocular surface disorders.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.